Preparation and evaluation of plumbagin-loaded lipid cubic liquid crystal nano-drug delivery system

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · Published 2026-04-21 · DOI 10.1080/10837450.2026.2669320

Authors being retrieved — see the publisher record. https://doi.org/10.1080/10837450.2026.2669320

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Camellia sinensis silver nanoparticles inhibit proliferation and induce PARP-dependent apoptosis in A549 cells: formulation, characterization, and biological evaluation · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2026 · Same journal
• Surface engineering of nanocarriers with polymer coatings: materials, strategies, functional outcomes, and clinical translation · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2026 · Same journal
• Synergistic nanogel therapy for dry and nutrient-deficient wounds: biotin-loaded acacia–alginate hydrogel enhances tissue regeneration and reduces inflammation · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2026 · Same journal
• The chrysin solid dispersion prepared using polyvinylpyrrolidone K40 demonstrates enhanced solubility and a thermogenesis-promoting effect on adipocytes · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2026 · Same journal
• The use of design of experiments and green chemistry for the preparation of a taste-masked metronidazole-loaded cubosomal nanostructured oral gel · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2026 · Same journal
• AI-guided real-time detection of flow irregularities and bottlenecks in pharmaceutical vial filling lines using vision-based models · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2025 · Same journal
• Recent progress in nanoparticulate lipid-based co-delivery systems containing gene-based cargoes for the treatment of oncological and non-oncological diseases · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2026 · Same journal
• Quality by design (QbD) development of a Soluplus/TPGS-based ternary amorphous solid dispersion for enhanced oral bioavailability of acacetin · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2025 · Same journal
• Fabrication of baicalin solid dispersion using the supercritical anti-solvent technology: optimization, characterization, and evaluation · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2025 · Same journal
• Bortezomib/SBE-β-cyclodextrin inclusion complex for improved anticancer performance: formulation, characterization, and biological evaluation · PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY · 2026 · Same journal